Anti-APOA1 antibody [EPR25446-9]
- RabMAb
- 20ul selling size
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal Apolipoprotein A I antibody. Suitable for WB and reacts with Mouse samples. Cited in 3 publications.
View Alternative Names
Apolipoprotein A-I, Apo-AI, ApoA-I, Apolipoprotein A1, Apoa1
- WB
Supplier Data
Western blot - Anti-APOA1 antibody [EPR25446-9] (AB300085)
Blocking and diluting buffer and concentration were 5% NFDM/TBST.
The expression profile/molecular weight observed is consistent with that described in the literature (PMID : 23969698, 23409054).
Low expression : brain (PMID : 1478650)
All lanes:
Western blot - Anti-APOA1 antibody [EPR25446-9] (ab300085) at 1/1000 dilution
Lane 1:
Mouse plasma at 20 µg
Lane 2:
Mouse lung tissue lysate at 20 µg
Lane 3:
Mouse brain tissue lysate at 20 µg
Lane 4:
Mouse kidney tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 30 kDa
Observed band size: 28 kDa
false
Exposure time: 15s
Related conjugates and formulations (1)
-
Anti-APOA1 antibody [EPR25446-9] (BSA and Azide free)
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APOA1 is instrumental in reverse cholesterol transport a process that removes excess cholesterol from cells and prevents lipid accumulation. APOA1 is part of the HDL complex and it directly interacts with various lipid molecules. It contributes to lipid homeostasis and has antioxidant properties reducing oxidative stress. APOA1 also has anti-inflammatory effects which play a role in maintaining cardiovascular health.
Pathways
The reverse cholesterol transport pathway is highly reliant on APOA1 functionality supporting cholesterol movement out of cells. In this pathway APOA1 interacts with ATP-binding cassette transporters like ABCA1 and ABCG1 which aid in transferring cholesterol to HDL particles. Additionally APOA1 is associated with the HDL metabolism pathway where it collaborates with other proteins such as Apolipoprotein A-II (APOA2) and Lecithin-Cholesterol Acyltransferase (LCAT) facilitating the conversion of nascent HDL into mature HDL.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112661 PubMed40502707
2025
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 6:103526 PubMed39708327
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of extracellular vesicles 12:e12364 PubMed37654045
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com